2020台灣生技月 Bio Taiwan 生物科技大展

2020 台灣生技月 南港展覽館

講師

Auto Segmentation App. for Predication of Arteriovenous Malformation

Biomedical EcoSystem development office in Taiwan, BEST

July 24th (Fri) 21:10 - 22:40 Entrepreneur Pitch 4

Auto Segmentation App. for Predication of Arteriovenous Malformation

Company Info

Name /Auto Segmentation App. for Predication of Arteriovenous Malformation

Address /19F, No.172-1, Sec. 2, Keelung Rd., Taipei city, Taiwan 106

Website /

Presenter

Name /Peng, Syu-Jyun

Title /Assistant Professor

Email /sjpeng2019@tmu.edu.tw

Telephone /(Work) 02-66382736 ext.1998

Fax /

Mobile /0918-246903

Company Type

Biotechnology

About the Company

The medical software of ASAP-AVM is co-developed by Taipei Medical University (TMU) and Taipei Veterans General Hospital (TVGH) to evaluate the radiotherapy risk for patients with arteriovenous malformation (AVM). ASAP-AVM can automatically detect the site of vascular

malformation in the brain tissue in a MRI image and calculate the actual content between normal brain tissue and AVM, respectively. For the neurological surgeons and radiologists, ASAP-AVM can provide personalized and accurate radiotherapy evaluation for AVM patients in real time, which can effectively reduce the brain damage and the incidence of complications including cerebral edema and epilepsy.

Brief Description of main products or services

By automatic clustering and fuzzy classification algorithm technology, we develop an "ASAP-brain radiotherapy risk assessment software", which can evaluate the treatment risk of patients with brain diseases immediately through MRI images, leading to reduce the probability of prognosis complications. The medical software of ASAP-AVM is codeveloped by Taipei Medical University (TMU) and Taipei Veterans
General Hospital (TVGH) to evaluate the radiotherapy risk for patients with arteriovenous malformation (AVM). ASAP-AVM can automatically detect the site of vascular malformation in the brain tissue in a MRI image and calculate the actual content between normal brain tissue and AVM, respectively. For the neurological surgeons and radiologists, ASAP-AVM can provide personalized and accurate radiotherapy evaluation for AVM patients in real time, which can effectively reduce the brain damage and the incidence of complications including cerebral edema and epilepsy.

Contact Person

Name /Barry WU

Email /barry0110@tmu.edu.tw

Phone /0922-720167